Crossmark

REDUCE trial: the effects of perineural dexamethasone on scalp nerve blocks for relief of postcraniotomy pain—a study protocol for a randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s13063-021-05747-y

Published Online: 2021-11-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhao, Chunmei

Jia, Zipu

Shrestha, Niti

Luo, Fang https://orcid.org/0000-0002-3584-0355
Funding

Funding for this research was provided by:

Capital’s Funds for Health Improvement and Research (No. 2020-2-2046)
License Information

Text and Data Mining valid from 2021-11-04

Version of Record valid from 2021-11-04
More Information

Article History

Received: 7 April 2021

Accepted: 25 October 2021

First Online: 4 November 2021

Declarations

:

: The IRB of Beijing Tiantan Hospital, Capital Medical University (Approval Number: KY 2018-034-02-9) approved the planned protocol. Informed consent will be required from all patients before inclusion in the study, and each participant will be informed that their participation will be voluntary and that they will be able to withdraw from the study at any time. The REDUCE trial protocol has been formulated in accordance with the Consolidated Standards of Reporting Trials (CONSORT) [] recommendations, and the protocol follows the SPIRIT 2013 statement [].

: These are available from the corresponding author on reasonable request, if the patients’ consent to have their data published. Written informed consent will be obtained from the participants and/or legal guardian (see online supplementary file 1).

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below